Bacil Pharma Limited
BACPHAR.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$358.54M
Close$
$0.41
98.4% downside
Current Fair Value
98.4% downsideOvervalued by 98.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $358.54 Million |
|---|---|
| Enterprise Value | $358.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.11 |
| Beta | 0.36 |
| Outstanding Shares | 13,970,300 |
Return
| Return on Equity | 2.65% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 53.58 |
|---|---|
| PEG | -52.32 |
| Price to Sales | - |
| Price to Book Ratio | 1.47 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -344.42 |
| Enterprise Value to Net Income | 54 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bacil Pharma Limited
2 employees
CEO: Ganpat Dhondu Salekar Bacil Pharma Limited operates as a specialist in the production and distribution of a diverse range of pharmaceutical, therapeutic, and botanical goods. Their primary manufacturing facility, situated in Lote-Parshuram, is additionally eq...